| HLA
Allele |
Controls
n = 524 |
LTI
n = 218 |
PTB
n = 318 |
Controls vs PTB |
LTI vs PTB |
| HLA-DRB1* |
n (%) |
n (%) |
n (%) |
Pa |
OR |
95%CI |
P |
OR |
95%CI |
| 01 |
68 (12.98) |
23 (10.55) |
43 (13.52) |
|
|
|
|
|
|
| 03 |
52 (9.92) |
19 (8.72) |
37 (11.64) |
|
|
|
|
|
|
| 04 |
62 (11.83) |
31 (14.22) |
55 (17.30) |
0.0374 |
1.55 |
1.04-2.29 |
|
|
|
| 07 |
103 (19.66) |
46 (21.10) |
44 (13.84) |
0.036 |
0.65 |
0.44-0.96 |
0.034 |
0.6 |
0.38-0.94 |
| 08 |
19 (3.63) |
15 (6.88) |
13 (4.09) |
|
|
|
|
|
|
| 09 |
5 (0.95) |
2 (0.92) |
2 (0.63) |
|
|
|
|
|
|
| 10 |
6 (1.14) |
3 (1.32) |
4 (1.26) |
|
|
|
|
|
|
| 11 |
49 (935) |
20 (9.17) |
31 (9.75) |
|
|
|
|
|
|
| 12 |
6 (1.14) |
0 (0.0) |
4 (1.26) |
|
|
|
|
|
|
| 13 |
74 (14.12) |
22 10.09) |
34 (10.69) |
|
|
|
|
|
|
| 14 |
10 (1.91) |
8 (3.67) |
11 (3.46) |
|
|
|
|
|
|
| 15 |
62 (11.83) |
26 |
35 (11.01) |
|
|
|
|
|
|
| 16 |
8 (1.52) |
3 (1.32) |
7 (2.20) |
|
|
|
|
|
|
aUncorrected p value. After Bonferroni correction for multiple comparisons p values were not significant
No significant differences were obtained when we compared between the other groups. One PTB patient could not be HLA typed and for this reason in all the tables n is
318 instead 320. |
